Abstract
Basement membranes are sheet like extracellular matrices that underlie or surround many cell types. They are crucial for key cellular events such as cell migration, proliferation, survival and differentiation. Vital components of all basement membranes are laminins, heterotrimeric combinations of different laminin chain isoforms. The different laminins and their subunits largely have a developmental and tissue specific distribution. To determine the function of laminin isoforms in pathological conditions, three model diseases were used. Special focus was on the vasculature, but also on the most blood vessel specific laminin chain, the laminin ?4 chain.
Atherosclerosis is an inflammatory process in large and medium sized arteries. During progression of atherosclerosis the vascular smooth muscle cells (VSMC) in the vessel wall become activated and start to migrate and proliferate. Extracellular matrix molecules are important for this process, but not much was known about VSMC laminin expression in health or disease. Therefore, this was studied in healthy and atherosclerotic vessels. Major laminin chains in VSMC were laminin ?2, ?4, ?5, ?2 and ?1. In plaques, the laminin ?1 chain was up-regulated and the laminin ?2 chain down-regulated and in a cell culture system, mimicking the events of VSMC activation, the laminin ?5 chain was also seen to be reduced.
Tumour growth and metastasis are both dependent on incorporation of vessels into the tumour. An approach to treat cancers would therefore be to inhibit endothelial cell proliferation and migration. The C-terminal part of the laminin ?4 chain, the LG4-5 domain, is proteolytically released. This domain was shown to be retained in the circulation and to reduce endothelial cell migration in vitro. Further studies showed that laminin ?4 LG4-5 inhibited new blood vessel formation both ex vivo as well as in vivo. Purified integrin ?3?1 was shown to bind laminin ?4LG4-5 and is therefore suggested as a potential receptor for laminin ?4LG4-5.
The extraocular muscles are selectively spared from muscle wasting in some muscular dystrophies, including a mouse model of muscular dystrophy arising from complete absence of laminin ?2 chain. This model was used to identify the cause of this exclusion. Immunohistochemical and quantitative PCR studies suggested that extraocular muscles were spared due to high expression of the laminin ?4 chain, which could enable a sustained activation of the integrin ?7X1?1D.
In conclusion laminin isoform transition and processing of chains appear to occur in several of societies major diseases.
Atherosclerosis is an inflammatory process in large and medium sized arteries. During progression of atherosclerosis the vascular smooth muscle cells (VSMC) in the vessel wall become activated and start to migrate and proliferate. Extracellular matrix molecules are important for this process, but not much was known about VSMC laminin expression in health or disease. Therefore, this was studied in healthy and atherosclerotic vessels. Major laminin chains in VSMC were laminin ?2, ?4, ?5, ?2 and ?1. In plaques, the laminin ?1 chain was up-regulated and the laminin ?2 chain down-regulated and in a cell culture system, mimicking the events of VSMC activation, the laminin ?5 chain was also seen to be reduced.
Tumour growth and metastasis are both dependent on incorporation of vessels into the tumour. An approach to treat cancers would therefore be to inhibit endothelial cell proliferation and migration. The C-terminal part of the laminin ?4 chain, the LG4-5 domain, is proteolytically released. This domain was shown to be retained in the circulation and to reduce endothelial cell migration in vitro. Further studies showed that laminin ?4 LG4-5 inhibited new blood vessel formation both ex vivo as well as in vivo. Purified integrin ?3?1 was shown to bind laminin ?4LG4-5 and is therefore suggested as a potential receptor for laminin ?4LG4-5.
The extraocular muscles are selectively spared from muscle wasting in some muscular dystrophies, including a mouse model of muscular dystrophy arising from complete absence of laminin ?2 chain. This model was used to identify the cause of this exclusion. Immunohistochemical and quantitative PCR studies suggested that extraocular muscles were spared due to high expression of the laminin ?4 chain, which could enable a sustained activation of the integrin ?7X1?1D.
In conclusion laminin isoform transition and processing of chains appear to occur in several of societies major diseases.
Original language | English |
---|---|
Qualification | Doctor |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 2006 Dec 16 |
Publisher | |
ISBN (Print) | 91-85559-68-7 |
Publication status | Published - 2006 |
Bibliographical note
Defence detailsDate: 2006-12-16
Time: 09:00
Place: GK-salen BMC
External reviewer(s)
Name: Gullberg, Donald
Title: Professor
Affiliation: University of Bergen
---
<div class="article_info">A Nyström, T Sasaki, J.F. Talts and A Hultgårdh-Nilsson. <span class="article_issue_date">2006</span>. <span class="article_title">Changes in vascular smooth muscle cell laminin expression in the transition from healthy aorta to atherosclerotic plaques.</span> (manuscript)</div>
<div class="article_info">A Nyström, H Yu, P Ekblom and J.F. Talts. <span class="article_issue_date">2006</span>. <span class="article_title">The natural extracellular matrix cleavage product, laminin alpha4LG4-5, is a novel endogenous angiogenesis inhibitor, lamstatin-4.</span> (submitted)</div>
<div class="article_info">A Nyström, J Holmblad, F Pedrosa-Domellöf, T Sasaki and M Durbeej. <span class="article_issue_date">2006</span>. <span class="article_title">Extraocular muscle is spared upon complete laminin alpha2 deficiency: Comparative expression of laminin and integrin isoforms.</span> <span class="journal_series_title">Matrix Biol.</span>, <span class="journal_volume">vol 25</span> <span class="journal_pages">pp 382-5</span>.</div>
Subject classification (UKÄ)
- Basic Medicine
Free keywords
- vasculature
- angiogenesis
- Medicine (human and vertebrates)
- disease
- LG domains
- Laminin
- Medicin (människa och djur)